Table 1: Drugs affected by mutations detected in six of the thirty-seven recently HIV positive individuals in RT-region of pol gene.

High Risk group/StateAGE& genderNRTINNRTIDrugs Affected

MSM Haryana26/MaleL74VIntermediate Resistance: Abacavir ( ABC)

IDU Chandigarh44/MaleK219NPotential Low Level Resistance: Zidovudine (AZT)

FSW Chandigarh25/FemaleK219RPotential Low Level Resistance: Zidovudine (AZT)

FSW Chandiagrh38/FemaleK219RPotential Low Level Resistance: Zidovudine (AZT)

IDU Chandigarh21/MaleY181C High-Level resistance: Nevirapine (NVP)
Intermediate Resistance: efavirenz (EFV), etravirine (ETR), rilpivirine (RPV)

IDU Chandigarh32/MaleY181CHigh-Level resistance: Nevirapine (NVP)
Intermediate Resistance: efavirenz (EFV), etravirine (ETR), rilpivirine (RPV)